Hollsteen
← Credo

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2020: $28.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Research and development · FY2021: $35.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Research and development · FY2022: $48.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Research and development · FY2023: $77.0M · 10-K 0001628280-23-023187 filed Jun 23, 2023Research and development · FY2024: $96.0M · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · FY2025: $147M · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · FY2026: $279M · 10-K 0001628280-26-043303 filed Jun 15, 2026missing7727928FY2016FY2026FY2023
$MResearch and development · FY2021: $35.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Research and development · FY2022: $48.0M · 10-K 0001628280-22-016593 filed Jun 8, 2022Research and development · FY2023: $77.0M · 10-K 0001628280-23-023187 filed Jun 23, 2023Research and development · FY2024: $96.0M · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · FY2025: $147M · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · FY2026: $279M · 10-K 0001628280-26-043303 filed Jun 15, 20267727935FY2021FY2026FY2023
FY2023
77$M
All values (7)
PeriodValue ($M)Status
FY2026279reported
FY2025147reported
FY202496reported
FY202377reported
FY202248reported
FY202135reported
FY202028reported
FY2016 – FY2019–missing (4 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: rnd

More metrics for Credo

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region

Sources & calculation
Value
$77.0M
Period
FY2023, ended Apr 29, 2023 · fiscal-year value (12 months)
Source
10-K, filed Jun 23, 2023 · 0001628280-23-023187
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$77.0MJun 23, 202310-K 0001628280-23-023187reported · confidence 1. · current